# RTW Investments LLC's Pharma Investments: 13 Startups in Its Portfolio (2026) > The 13 Pharma startups RTW Investments LLC has backed, by stage: $3.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/rtw-investments-lp-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 10 - [Mineralys Therapeutics](https://millionrounds.com/company/mineralys-therapeutics) - [Dianthus Therapeutics](https://millionrounds.com/company/dianthus-therapeutics) - [Cullinan Therapeutics](https://millionrounds.com/company/cullinan-therapeutics) - [GH Research](https://millionrounds.com/company/gh-research) - [Jade Biosciences](https://millionrounds.com/company/jade-biosciences) - [Tarsus Pharmaceuticals](https://millionrounds.com/company/tarsus-pharmaceuticals) - [Verastem Oncology](https://millionrounds.com/company/verastem-oncology) - [Whitehawk Therapeutics](https://millionrounds.com/company/whitehawk-therapeutics) - [ImageneBio](https://millionrounds.com/company/imagenebio) - [Ventyx Biosciences](https://millionrounds.com/company/ventyx-biosciences) ## Series C and later 3 - [ACELYRIN](https://millionrounds.com/company/acelyrin) - [Artios Pharma](https://millionrounds.com/company/artios-pharma) - [Umoja Biopharma](https://millionrounds.com/company/umoja-biopharma) ## Segment by segment ### Stage not reported 10 startups · $2.6B raised - [**Mineralys Therapeutics**](https://millionrounds.com/company/mineralys-therapeutics) Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension. United States $788M - [**Dianthus Therapeutics**](https://millionrounds.com/company/dianthus-therapeutics) Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach. United States $719M - [**Cullinan Therapeutics**](https://millionrounds.com/company/cullinan-therapeutics) Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly. United States $280M - [**GH Research**](https://millionrounds.com/company/gh-research) GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness. Ireland $268M - [**Jade Biosciences**](https://millionrounds.com/company/jade-biosciences) Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. United States $195M - [**Tarsus Pharmaceuticals**](https://millionrounds.com/company/tarsus-pharmaceuticals) Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need. United States $125M - [**Verastem Oncology**](https://millionrounds.com/company/verastem-oncology) Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers. United States $90M - [**Whitehawk Therapeutics**](https://millionrounds.com/company/whitehawk-therapeutics) Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology. United States $88M ### Series C and later 3 startups · $548M raised - [**ACELYRIN**](https://millionrounds.com/company/acelyrin) ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies. United States $300M - [**Artios Pharma**](https://millionrounds.com/company/artios-pharma) Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies. United Kingdom $148M - [**Umoja Biopharma**](https://millionrounds.com/company/umoja-biopharma) Umoja Biopharma is a clinical-stage biotechnology company based in Seattle, Washington, founded in 2019. United States $100M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names RTW Investments LLC as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **RTW Investments LLC's Biotech portfolio** 52 startups · $11B](https://millionrounds.com/portfolio-maps/rtw-investments-lp-biotech-portfolio)[Portfolio map **RTW Investments LLC portfolio map** 69 startups · $14B](https://millionrounds.com/portfolio-maps/rtw-investments-lp-portfolio-map)[Co-investors **Who invests with RTW Investments LLC** 47 co-investors](https://millionrounds.com/portfolio-maps/rtw-investments-lp-co-investors)[Sector portfolio **Citibank's Fintech portfolio** 79 startups · $17B](https://millionrounds.com/portfolio-maps/citi-fintech-portfolio)[Sector portfolio **Citibank's AI portfolio** 50 startups · $64B](https://millionrounds.com/portfolio-maps/citi-ai-portfolio)[Sector portfolio **Bond's AI portfolio** 31 startups · $15B](https://millionrounds.com/portfolio-maps/bond-ai-portfolio) ## Raising from investors like RTW Investments LLC? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)